GE HealthCare Technologies (GEHC) Cash & Equivalents (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported Cash & Equivalents for 5 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 44.03% year-over-year to $2.1 billion; the trailing twelve-month figure through Jun 2026 stood at $2.1 billion (down 44.03% YoY), and the FY2025 full-year result was $4.5 billion, up 56.07% from the prior year.
• Cash & Equivalents retreated to $2.1 billion in Q2 2026 per GEHC's latest filing, from $2.3 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $4.5 billion in Q4 2025 and bottomed at $504.0 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $2.4 billion across 5 years, with a median of $2.4 billion in 2023.
• The sharpest annual moves came in 2023 and 2026: Cash & Equivalents surged 380.16% in 2023, then tumbled 44.03% in 2026.
• Over 5 years, Cash & Equivalents stood at $1.5 billion in 2022, then jumped by 72.71% to $2.5 billion in 2023, then rose by 15.44% to $2.9 billion in 2024, then jumped by 56.07% to $4.5 billion in 2025, then slumped by 53.31% to $2.1 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $2.1 billion, $2.3 billion, and $4.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.